利用常规生化残余血样连续监测儿童SARS-CoV-2血清流行率
本研究在三个时间段收集0-17岁儿科患者匿名残余血样,检测SARS-CoV-2刺突蛋白(anti-S)和核衣壳蛋白(anti-N)抗体,并与国家监测数据比较。共分析2626份样本,未接种疫苗儿童中anti-S和anti-N血清流行率随时间上升,漏报病例数为监测数据的3.93-5.66倍。研究表明常规实验室残余血样可用于估计儿童总SARS-CoV-2血清流行率。
要点
- 残余血样中anti-S和anti-N血清流行率在三个时间段均上升
- 漏报病例数为国家监测数据的3.93-5.66倍
- 各省累计发病率与分配数据相关(r=0.74,p=0.0151)
核心结论
- 常规实验室化学残余血样可用于估计儿童总SARS-CoV-2血清流行率。
研究设计与样本
- 共分析2626份个体血样,使用商业抗体检测anti-S和anti-N抗体,28份反应性样本用假型中和试验比较抗体水平。
主要发现
- anti-S血清流行率在三个时间段分别为1.38%、9.16%和14.59%。
- anti-N血清流行率在三个时间段分别为1.26%、6.19%和8.56%。
- 漏报病例数为国家监测数据的3.93-5.66倍。
- 各省累计发病率与分配数据相关(r=0.74,p=0.0151)。
- anti-S和anti-N反应性样本及仅anti-S样本显示中和能力(分别为11/14和8/14)。
关键数值与推荐
- anti-S血清流行率:1.38-9.16%和14.59%;anti-N血清流行率:1.26%、6.19%和8.56%。
- 漏报病例数为监测数据的3.93-5.66倍。
- 各省累计发病率与分配数据相关(r=0.74,p=0.0151)。
- anti-S和anti-N反应性样本中和能力为11/14,仅anti-S样本为8/14。
- anti-S水平在年龄组和性别间无显著差异(所有p>0.05)。
临床怎么用
- 可利用常规实验室化学残余血样进行儿童SARS-CoV-2血清流行率监测。
- 血清流行率数据可辅助估计漏报病例数,支持公共卫生决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The assessment of SARS-CoV-2 infections in children is still challenging, but essential for appropriate political decisions. The aim of this study was to investigate whether residual blood samples can be used for SARS-CoV-2 seroprevalence monitoring in pediatrics. METHODS: In this repeated cross-sectional cohort study, anonymous residual blood samples from pediatric patients aged 0-17 years were collected in three time-periods (Oct.-Nov. 2020, April 2021, and June-July 2021) and analyzed for SARS-CoV-2 Spike protein (anti-S) and nucleocapsid (anti-N) antibodies using commercial antibody assays. 28 reactive samples were used to compare antibody levels with a pseudotyped neutralization assay. The results were further compared to the official national COVID-19 surveillance data to calculate the number of unreported cases. RESULTS: In total, n=2,626 individual blood samples were analyzed. In this unvaccinated pediatric cohort anti-S and anti-N antibody seroprevalence increased over the three time periods (anti-S: 1.38-9.16%, and 14.59%; anti-N: 1.26%, to 6.19%, and 8.56%). Compared to the national surveillance data this leads to a 3.93-5.66-fold increase in the number of unreported cases. However, a correlation between the cumulative incidence of the individual provinces and our assigned data was found (r=0.74, p=0.0151). In addition, reactive samples with anti-S and anti-N and samples with only anti-S showed neutralization capabilities (11/14 and 8/14, respectively). Anti-S levels were not significantly different between age groups and sexes (all p>0.05). CONCLUSIONS: The present study suggests that residual blood samples from routine laboratory chemistry could be included in the estimation of the total SARS-CoV-2 seroprevalence in children.
引用
- Wachter F, Regensburger AP, Antonia Sophia Peter, et al. Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry. Clin Chem Lab Med. 2022. PMID: 35218170. doi:10.1515/cclm-2022-0037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。